Reduced antioxidant defense in early onset first-episode psychosis: a case-control study

dc.contributor.authorMicó, Juan Antonio
dc.contributor.authorRojas Corrales, Maria Olga
dc.contributor.authorGibert Rahola, Juan
dc.contributor.authorParellada, Mara
dc.contributor.authorMoreno, Dolores
dc.contributor.authorFraguas, David
dc.contributor.authorGraell, Montserrat
dc.contributor.authorGil, Javier
dc.contributor.authorIrazusta, Jon
dc.contributor.authorCastro Fornieles, Josefina
dc.contributor.authorSoutullo, Cesar
dc.contributor.authorArango, Celso
dc.contributor.authorOtero, Soraya
dc.contributor.authorNavarro, Ana
dc.contributor.authorBaeza, Inmaculada, 1970-
dc.contributor.authorMartínez Cengotitabengoa, Mónica
dc.contributor.authorGonzález-Pinto, Ana
dc.date.accessioned2013-04-24T10:05:18Z
dc.date.available2013-04-24T10:05:18Z
dc.date.issued2011-02-14
dc.date.updated2013-04-24T10:05:18Z
dc.description.abstractBackground:Our objective is to determine the activity of the antioxidant defense system at admission in patients with early onset first psychotic episodes compared with a control group. Methods: Total antioxidant status (TAS) and lipid peroxidation (LOOH) were determined in plasma. Enzyme activities and total glutathione levels were determined in erythrocytes in 102 children and adolescents with a first psychotic episode and 98 healthy controls. Results: A decrease in antioxidant defense was found in patients, measured as decreased TAS and glutathione levels. Lipid damage (LOOH) and glutathione peroxidase activity was higher in patients than controls. Our study shows a decrease in the antioxidant defense system in early onset first episode psychotic patients. Conclusions: Glutathione deficit seems to be implicated in psychosis, and may be an important indirect biomarker of oxidative stress in early-onset schizophrenia. Oxidative damage is present in these patients, and may contribute to its pathophysiology.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec587053
dc.identifier.issn1471-244X
dc.identifier.pmid21320302
dc.identifier.urihttps://hdl.handle.net/2445/35753
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.1186/1471-244X-11-26
dc.relation.ispartofBMC Psychiatry, 2011, vol. 11, p. 26
dc.relation.urihttp://dx.doi.org/10.1186/1471-244X-11-26
dc.rightscc-by (c) Micó,J.A. et al., 2011
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Psicologia Clínica i Psicobiologia)
dc.subject.classificationPsicosi
dc.subject.classificationGlutatió
dc.subject.classificationEstrès oxidatiu
dc.subject.otherPsychoses
dc.subject.otherGlutathione
dc.subject.otherOxidative stress
dc.titleReduced antioxidant defense in early onset first-episode psychosis: a case-control study
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
587053.pdf
Mida:
259.06 KB
Format:
Adobe Portable Document Format